(19)
(11) EP 4 452 417 A1

(12)

(43) Date of publication:
30.10.2024 Bulletin 2024/44

(21) Application number: 22844175.4

(22) Date of filing: 23.12.2022
(51) International Patent Classification (IPC): 
A61P 35/02(2006.01)
C07K 14/725(2006.01)
C07K 14/705(2006.01)
 C07K 16/28(2006.01)
A61K 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/02; C07K 2319/03; C07K 16/289; C07K 14/7051; C07K 14/70589; C07K 2317/55; C07K 2317/92; C07K 2317/34; C07K 2317/77
(86) International application number:
PCT/EP2022/087829
(87) International publication number:
WO 2023/118608 (29.06.2023 Gazette 2023/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 23.12.2021 EP 21217465

(71) Applicants:
  • Universität Basel
    4003 Basel (CH)
  • Cimeio Therapeutics AG
    4051 Basel (CH)

(72) Inventors:
  • URLINGER, Stefanie
    81476 MUNCHEN (DE)
  • JEKER, Lukas
    4125 RIEHEN (CH)
  • LEPORE, Rosalba
    4051 BASEL (CH)
  • MATTER MARONE, Romina
    4125 RIEHEN (CH)
  • CAMUS, Anna
    4054 BASEL (CH)
  • SINOPOLI, Alessandro
    68300 SAINT-LOUIS (FR)
  • DURZYNSKA, Izabela
    4052 BASEL (CH)
  • HAYDN, Anna
    8046 ZURICH (CH)
  • DEVAUX, Anna
    68300 SAINT-LOUIS (FR)
  • GARAUDE, Simon
    4053 BASEL (CH)

(74) Representative: Plasseraud IP 
104 Rue de Richelieu CS92104
75080 Paris Cedex 02
75080 Paris Cedex 02 (FR)

   


(54) DISCERNIBLE CELL SURFACE PROTEIN VARIANTS OF CD45 FOR USE IN CELL THERAPY